Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 1-7 , February 2010

Cell turnover in apocrine metaplasia and apocrine adenosis of the breast

  • Ghada Elayat, MBChB, MSc, PhD

      Affiliations

    • Department of Histopathology, St Bartholomew's Hospital, West Smithfield, EC1A 7BE London, UK
    • ,
  • Abdel-Ghani A Selim, MBChB, MSc, PhD, FRCPath

      Affiliations

    • Department of Histopathology, King's College Hospital, Denmark Hill, SE5 9RS London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0 20 32993605; fax: +44 0 20 32993670.
    • ,
  • Clive A Wells, MA MBBChir, FRCPath

      Affiliations

    • Department of Histopathology, St Bartholomew's Hospital, West Smithfield, EC1A 7BE London, UK

References 

  1. Ferguson D, Anderson T. Ultrastructural observations on cell death by apoptosis in the resting human breast. Virchows Arch A Pathol Anat Histpathol. 1981;393:193–203
  2. Ferguson D. An ultrastructural study of mitosis and cytokinesis in normal resting human breast. Cell Tissue Res. 1988;252:581–587
  3. Feuerhake F, Sigg W, Hofter E, et al. Immunohistochemical analysis of bcl-2 and bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium. Cell Tissue Res. 2000;299:47–58
  4. Krajewski S, Bodrug S, Krajweska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in-vivo. Am J Pathol. 1995;146:1309–1319
  5. Feuerhake F, Unterberger P, Hofter EA. Cell turnover in apocrine metaplasia of the human mammary gland epithelium: apoptosis, proliferation and immunohistochemical detection of bcl-2, bax, EGFR and c-erbB-2 gene products. Acta Histochem. 2001;103:53–65
  6. Tavassoli F, Purcell C, Bratthauer G, et al. Androgen receptor expression along with loss of Bcl-2, ER, and PR expression in benign and malignant apocrine lesions of the breast: Implications of therapy. Breast J. 1996;2:261–269
  7. Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol. 2001;32:487–493
  8. Selim A, El-Ayat G, Wells C. Expression of c-erbB-2, p53, Bcl-2, Bax, c-myc and ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch. 2002;441:449–455
  9. Kolquist K, Ellisen L, Counter C, Meyerson MM, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature genetic. 1998;19:182–186
  10. Yashima K, Milchgrub S, Gollahon L, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res. 1998;4:229–234
  11. Page D, Dupont W, Jensen R. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol, Biomarkers Preven. 1996;5:29–32
  12. Wells C, McGregor I, Makunura C, et al. Apocrine adenosis: a precursor of aggressive breast cancer?. J Clin Pathol. 1995;48:737–742
  13. Seidman J, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast. A clinicopathologic study of 37 patients with 8.7 year follow up. Cancer. 1996;77:2529–2537
  14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577–580
  15. Norton A, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol. 1994;173:371–379
  16. Yan P, Benhattar J, Seelentag W, et al. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol. 2004;121:391–397
  17. Washington C, Dalbegue F, Abreo F, et al. Loss of heterozigosity in fibrocystic change of the breast. Genetic relationship between benign proliferative lesions and associated carcinomas. Am J Pathol. 2000;157:323–329
  18. Jones C, Damiani S, Wells D, et al. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol. 2001;158:207–214
  19. Selim AA, Ryan A, El-Ayat G, et al. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis. J Pathol. 2002;196:287–291
  20. Shigemasa K, Katoh O, Shiroyama Y, et al. Increased Mcl-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J cancer Res. 2002;93:542–550
  21. Selim A, El-Ayat G, Wells C. C-erbB2 oncoprotein expression, gene amplification and chromosome 17 aneusomy in apocrine adenosis of the breast. J Pathol. 2000;191:138–142
  22. Endoh Y, Tamura G, Kato N, et al. Apocrine adenosis of the breast: clonal evidence of neoplasia. Histopathology. 2001;38:221–224
  23. Selim A, Ryan A, El-Ayat G, et al. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast. Cancer Detect prev. 2001;25:262–267
  24. Schmitt F, Reis-Filho J. Oncogenes, granules and breast cancer: what has c-myc to do with apocrine changes?. Breast. 2002;11:463–465
  25. Ioffe O, Iskander M, Rucker C, et al. Benign, malignant and pseudo-malignant apocrine lesions of the breast: another attempt at differential diagnosis. Lab Invest. 1999;79:111;(abstr)
  26. Ioffe O, Iskander M, Rucker C, et al. A comparative study of c-erbB-2, p27, bcl-2 and Ki-67 expression in apocrine proliferations and benign breast tissue. Lab Invest. 1999;79:112;(abst)
  27. Moriya T, Sakamoto K, Sasano H, Kawanaka M, et al. Immunohistochemical analysis of Ki-67, p53, p21 and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol. 2000;13:13–18
  28. Simpson J, Page D, Dupont W. Apocrine adenosis—a mimic of mammary carcinoma. Am J Surg Pathol. 1990;3:289–299
  29. Ikeda S, Shibata T, Eishi Y, et al. Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunohistochemical restaining method. Pathol Int. 2003;53:762–768

PII: S1092-9134(09)00055-0

doi: 10.1016/j.anndiagpath.2009.05.001

Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 1-7 , February 2010

Article Tools

* Image Usage & Resolution